457 related articles for article (PubMed ID: 9338580)
21. Establishment and characterization of spontaneously immortalized Schwann cells from murine model of globoid cell leukodystrophy (twitcher).
Shen JS; Watabe K; Meng XL; Ida H; Ohashi T; Eto Y
J Neurosci Res; 2002 Jun; 68(5):588-94. PubMed ID: 12111848
[TBL] [Abstract][Full Text] [Related]
22. GALC transduction leads to morphological improvement of the twitcher oligodendrocytes in vivo.
Meng XL; Shen JS; Watabe K; Ohashi T; Eto Y
Mol Genet Metab; 2005 Apr; 84(4):332-43. PubMed ID: 15781194
[TBL] [Abstract][Full Text] [Related]
23. Insights into the Pathogenesis and Treatment of Krabbe Disease.
Bongarzone ER; Escolar ML; Gray SJ; Kafri T; Vite CH; Sands MS
Pediatr Endocrinol Rev; 2016 Jun; 13 Suppl 1():689-96. PubMed ID: 27491217
[TBL] [Abstract][Full Text] [Related]
24. Residual galactosylsphingosine (psychosine) beta-galactosidase activities and associated GALC mutations in late and very late onset Krabbe disease.
Harzer K; Knoblich R; Rolfs A; Bauer P; Eggers J
Clin Chim Acta; 2002 Mar; 317(1-2):77-84. PubMed ID: 11814461
[TBL] [Abstract][Full Text] [Related]
25. Intravenous injection of AAVrh10-GALC after the neonatal period in twitcher mice results in significant expression in the central and peripheral nervous systems and improvement of clinical features.
Rafi MA; Rao HZ; Luzi P; Luddi A; Curtis MT; Wenger DA
Mol Genet Metab; 2015 Mar; 114(3):459-66. PubMed ID: 25533112
[TBL] [Abstract][Full Text] [Related]
26. A novel homozygous GALC mutation: very early onset and rapidly progressive Krabbe disease.
Kardas F; Uzak AS; Hossain MA; Sakai N; Canpolat M; Yıkılmaz A
Gene; 2013 Mar; 517(1):125-7. PubMed ID: 23276707
[TBL] [Abstract][Full Text] [Related]
27. Globoid cell leukodystrophy in cairn and West Highland white terriers.
Wenger DA; Victoria T; Rafi MA; Luzi P; Vanier MT; Vite C; Patterson DF; Haskins MH
J Hered; 1999; 90(1):138-42. PubMed ID: 9987921
[TBL] [Abstract][Full Text] [Related]
28. Single-dose intracerebroventricular administration of galactocerebrosidase improves survival in a mouse model of globoid cell leukodystrophy.
Lee WC; Tsoi YK; Troendle FJ; DeLucia MW; Ahmed Z; Dicky CA; Dickson DW; Eckman CB
FASEB J; 2007 Aug; 21(10):2520-7. PubMed ID: 17403939
[TBL] [Abstract][Full Text] [Related]
29. Adult-onset Krabbe's disease in siblings with novel mutations in the galactocerebrosidase gene.
Bernardini GL; Herrera DG; Carson D; DeGasperi R; Gama Sosa MA; Kolodny EH; Trifiletti R
Ann Neurol; 1997 Jan; 41(1):111-4. PubMed ID: 9005874
[TBL] [Abstract][Full Text] [Related]
30. A single mutation in the GALC gene is responsible for the majority of late onset Krabbe disease patients in the Catania (Sicily, Italy) region.
Lissens W; Arena A; Seneca S; Rafi M; Sorge G; Liebaers I; Wenger D; Fiumara A
Hum Mutat; 2007 Jul; 28(7):742. PubMed ID: 17579360
[TBL] [Abstract][Full Text] [Related]
31. Retroviral vector-mediated transfer of the galactocerebrosidase (GALC) cDNA leads to overexpression and transfer of GALC activity to neighboring cells.
Rafi MA; Fugaro J; Amini S; Luzi P; de Gala G; Victoria T; Dubell C; Shahinfar M; Wenger DA
Biochem Mol Med; 1996 Aug; 58(2):142-50. PubMed ID: 8812733
[TBL] [Abstract][Full Text] [Related]
32. Late-onset Krabbe disease is predominant in Japan and its mutant precursor protein undergoes more effective processing than the infantile-onset form.
Hossain MA; Otomo T; Saito S; Ohno K; Sakuraba H; Hamada Y; Ozono K; Sakai N
Gene; 2014 Jan; 534(2):144-54. PubMed ID: 24252386
[TBL] [Abstract][Full Text] [Related]
33. Biochemical and pathological evaluation of long-lived mice with globoid cell leukodystrophy after bone marrow transplantation.
Luzi P; Rafi MA; Zaka M; Rao HZ; Curtis M; Vanier MT; Wenger DA
Mol Genet Metab; 2005; 86(1-2):150-9. PubMed ID: 16169269
[TBL] [Abstract][Full Text] [Related]
34. Galactosylceramidase deficiency and pathological abnormalities in cerebral white matter of Krabbe disease.
Iacono D; Koga S; Peng H; Manavalan A; Daiker J; Castanedes-Casey M; Martin NB; Herdt AR; Gelb MH; Dickson DW; Lee CW
Neurobiol Dis; 2022 Nov; 174():105862. PubMed ID: 36113749
[TBL] [Abstract][Full Text] [Related]
35. Characterization and application of a disease-cell model for a neurodegenerative lysosomal disease.
Ribbens JJ; Moser AB; Hubbard WC; Bongarzone ER; Maegawa GH
Mol Genet Metab; 2014 Feb; 111(2):172-83. PubMed ID: 24094551
[TBL] [Abstract][Full Text] [Related]
36. Clinical and biochemical heterogeneity of globoid cell leukodystrophy.
Farrell DF; Swedberg K
Ann Neurol; 1981 Oct; 10(4):364-8. PubMed ID: 7316489
[TBL] [Abstract][Full Text] [Related]
37. Globoid cell leukodystrophy (Krabbe's disease): update.
Suzuki K
J Child Neurol; 2003 Sep; 18(9):595-603. PubMed ID: 14572137
[TBL] [Abstract][Full Text] [Related]
38. Enzyme replacement therapy results in substantial improvements in early clinical phenotype in a mouse model of globoid cell leukodystrophy.
Lee WC; Courtenay A; Troendle FJ; Stallings-Mann ML; Dickey CA; DeLucia MW; Dickson DW; Eckman CB
FASEB J; 2005 Sep; 19(11):1549-51. PubMed ID: 15987783
[TBL] [Abstract][Full Text] [Related]
39. A large deletion together with a point mutation in the GALC gene is a common mutant allele in patients with infantile Krabbe disease.
Rafi MA; Luzi P; Chen YQ; Wenger DA
Hum Mol Genet; 1995 Aug; 4(8):1285-9. PubMed ID: 7581365
[TBL] [Abstract][Full Text] [Related]
40. Mechanism-based combination treatment dramatically increases therapeutic efficacy in murine globoid cell leukodystrophy.
Hawkins-Salsbury JA; Shea L; Jiang X; Hunter DA; Guzman AM; Reddy AS; Qin EY; Li Y; Gray SJ; Ory DS; Sands MS
J Neurosci; 2015 Apr; 35(16):6495-505. PubMed ID: 25904800
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
